Jason Rizzo, MD: Utility of Gene Expression Profile Testing for Prognosis in Cutaneous Melanoma

October 15, 2025

Dr. Rizzo discusses how the 31-GEP test can inform routine imaging guidance and provides improved risk stratification in patients with melanoma.

MORE EXPERT PERSPECTIVES IN MELANOMA:

Jason Rizzo, MD, PhD: Evaluating Melanoma-specific Survival Stratification and Survival Benefit of Gene Testing in Patients with Melanoma

Brent Moody, MD: Assessing the Prognostic Significance of the 31-gene Expression Profile Test

Abel Jarell, MD, FAAD: Identifying the Risk of Central Nervous System Metastasis Using the 31-Gene Expression Profile Test

Hadas Skupsky, MD, FAAD: Pigmented Lesion Management for the Dermatologist

©2026 Oncology Matrix. All Rights Reserved.